These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23249110)

  • 1. β-adrenergic-blocking drugs and melanoma: current state of the art.
    De Giorgi V; Grazzini M; Gandini S; Benemei S; Asbury CD; Marchionni N; Geppetti P
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1461-7. PubMed ID: 23249110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [β-blockers: a new and emerging treatment for melanoma].
    De Giorgi V; Gandini S; Grazzini M; Benemei S; Marchionni N; Geppetti P
    Recenti Prog Med; 2012 Jan; 103(1):11-6. PubMed ID: 22322621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with β-blockers and reduced disease progression in patients with thick melanoma.
    De Giorgi V; Grazzini M; Gandini S; Benemei S; Lotti T; Marchionni N; Geppetti P
    Arch Intern Med; 2011 Apr; 171(8):779-81. PubMed ID: 21518948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of β-Blockers in Melanoma.
    De Giorgi V; Geppetti P; Lupi C; Benemei S
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):17-26. PubMed ID: 31482435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blocking drugs in breast cancer: a perspective review.
    Barron TI; Sharp L; Visvanathan K
    Ther Adv Med Oncol; 2012 May; 4(3):113-25. PubMed ID: 22590485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adrenergic signaling in breast cancer biology.
    Obeid EI; Conzen SD
    Cancer Biomark; 2013; 13(3):161-9. PubMed ID: 23912488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blockers and breast cancer mortality: a population- based study.
    Barron TI; Connolly RM; Sharp L; Bennett K; Visvanathan K
    J Clin Oncol; 2011 Jul; 29(19):2635-44. PubMed ID: 21632503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic blockers and breast cancer.
    Med Lett Drugs Ther; 2012 Jan; 54(1382):6-7. PubMed ID: 22267215
    [No Abstract]   [Full Text] [Related]  

  • 9. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: implications for anti-cancer drug targets.
    Al-Wadei HA; Ullah MF; Al-Wadei MH
    Pharmacol Res; 2012 Jul; 66(1):33-40. PubMed ID: 22487140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.
    Coelho M; Soares-Silva C; Brandão D; Marino F; Cosentino M; Ribeiro L
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):275-291. PubMed ID: 27709364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β
    Dal Monte M; Calvani M; Cammalleri M; Favre C; Filippi L; Bagnoli P
    Br J Pharmacol; 2019 Jul; 176(14):2496-2508. PubMed ID: 30471093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
    Kim KB
    Cancer; 2013 Feb; 119(3):477-80. PubMed ID: 22915026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology.
    Bristow MR
    Circ Res; 2011 Oct; 109(10):1176-94. PubMed ID: 22034480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatment of malignant melanoma: grade is as important as stage.
    Retsas S
    Clin Exp Dermatol; 1997 Mar; 22(2):67-71. PubMed ID: 9330068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can propranolol prevent progression of melanoma?
    Kao J; Luu B
    JAAPA; 2019 Jun; 32(6):1-5. PubMed ID: 31136408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta in cutaneous melanoma.
    Javelaud D; Alexaki VI; Mauviel A
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trials in melanoma: an update.
    Eggermont AM
    Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.